Faron Pharmaceuticals - Innovative medical solutions (Part 2)

Light summer reading :wink: including topics such as the tumor microenvironment and a small section on modulating the tumor immune microenvironment. Bex is mentioned in section 6.5: The humanized antibody bexmarilimab, which targets Clever-1, enhances IFN-γ signaling activity in TAMs (tumor-associated macrophages), promotes the secretion of CXCL10, and facilitates T-cell infiltration into the ovarian cancer TME (tumor microenvironment).

https://www.sciencedirect.com/science/article/pii/S1043661826001696?fr=RR-2&ref=pdf_download&rr=a170823b3f349a02

12 Likes